The leading microbiome company in oncology

We are a clinical-stage microbiome therapeutics company
aiming to improve survival in cancer.

Our strengths

A full ecosystem approach

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

May 15, 2024

May 15, 2024: MaaT Pharma announces the successful completion of its Global Offering of 19.2 Million Euros

May 14, 2024

May 14, 2024: MaaT Pharma Launches a Global Offering of approximately 18 Million Euros

May 7, 2024

May 7, 2024: MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2024

Like what you see? See more posts

Join the MaaT Pharma adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!